These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9222045

  • 41. Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea.
    Lee JK, Lee YS, Park YK, Kim BS.
    Microbiol Immunol; 2005; 49(7):647-53. PubMed ID: 16034208
    [Abstract] [Full Text] [Related]

  • 42. A mutation in QRDR in the ParC subunit of topoisomerase IV was responsible for fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
    Choi H, Lee HJ, Lee Y.
    Yonsei Med J; 1998 Dec; 39(6):541-5. PubMed ID: 10097681
    [Abstract] [Full Text] [Related]

  • 43. Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium.
    el Amin NA, Jalal S, Wretlind B.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):947-9. PubMed ID: 10103206
    [Abstract] [Full Text] [Related]

  • 44. In vitro antibacterial activities of new fluoroquinolones against clinical isolates of haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC.
    Yoshizumi S, Takahashi Y, Watanabe Y, Okezaki E, Ishii Y, Tateda K.
    Chemotherapy; 2004 Dec; 50(6):265-75. PubMed ID: 15608441
    [Abstract] [Full Text] [Related]

  • 45. Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae.
    Trees DL, Sandul AL, Whittington WL, Knapp JS.
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2103-5. PubMed ID: 9687414
    [Abstract] [Full Text] [Related]

  • 46. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom.
    Piddock LJ, Ricci V, McLaren I, Griggs DJ.
    J Antimicrob Chemother; 1998 Jun; 41(6):635-41. PubMed ID: 9687102
    [Abstract] [Full Text] [Related]

  • 47. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS, Yague G, Fisher LM.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
    [Abstract] [Full Text] [Related]

  • 48. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
    Eaves DJ, Randall L, Gray DT, Buckley A, Woodward MJ, White AP, Piddock LJ.
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
    [Abstract] [Full Text] [Related]

  • 49. Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.
    Schmitz FJ, Jones ME, Hofmann B, Hansen B, Scheuring S, Lückefahr M, Fluit A, Verhoef J, Hadding U, Heinz HP, Köhrer K.
    Antimicrob Agents Chemother; 1998 May; 42(5):1249-52. PubMed ID: 9593159
    [Abstract] [Full Text] [Related]

  • 50. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
    Tanaka M, Sakuma S, Takahashi K, Nagahuzi T, Saika T, Kobayashi I, Kumazawa J.
    Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
    [Abstract] [Full Text] [Related]

  • 51. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X, Lind I.
    Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
    [Abstract] [Full Text] [Related]

  • 52. Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
    Deguchi T, Yasuda M, Nakano M, Kanematsu E, Ozeki S, Ishihara S, Saito I, Kawada Y.
    J Antimicrob Chemother; 1997 Feb; 39(2):247-9. PubMed ID: 9069547
    [Abstract] [Full Text] [Related]

  • 53. [Analysis of regions determining resistence to fluoroquinolones in genes gyrA and parC in clinical isolates of Mycoplasma hominis].
    Gushchin AE, Ladygina VG, Govorun VM, Taraskina AM, Savicheva AM.
    Mol Gen Mikrobiol Virusol; 2000 Feb; (4):33-5. PubMed ID: 11186458
    [Abstract] [Full Text] [Related]

  • 54. Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates.
    Taylor DE, Chau AS.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):665-71. PubMed ID: 9056011
    [Abstract] [Full Text] [Related]

  • 55. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.
    Musso D, Drancourt M, Osscini S, Raoult D.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):870-3. PubMed ID: 8849242
    [Abstract] [Full Text] [Related]

  • 56. Isolation of quinolone-resistant Escherichia coli found in major rivers in Korea.
    Jung D, Lee MY, Kim JM, Lee JC, Cho DT, Lee Y.
    J Microbiol; 2006 Dec; 44(6):680-4. PubMed ID: 17205049
    [Abstract] [Full Text] [Related]

  • 57. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC, Wang HB, Sun ZY, Shen ZY.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):403-7. PubMed ID: 12820918
    [Abstract] [Full Text] [Related]

  • 58. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda.
    Kim MS, Jun LJ, Shin SB, Park MA, Jung SH, Kim K, Moon KH, Jeong HD.
    J Microbiol Biotechnol; 2010 Dec 10; 20(12):1735-43. PubMed ID: 21193831
    [Abstract] [Full Text] [Related]

  • 59. Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates.
    Vila J, Ribera A, Marco F, Ruiz J, Mensa J, Chaves J, Hernandez G, Jimenez De Anta MT.
    J Antimicrob Chemother; 2002 Mar 10; 49(3):471-7. PubMed ID: 11864947
    [Abstract] [Full Text] [Related]

  • 60. Analysis of grlA mutations in clinical isolates of Staphylococcus aureus with different levels of quinolone resistance.
    Martínez JA, Ortiz G, Segovia M, Alonso MA, Gutiérrez MN, Muñoz JL, García-Rodríguez JA.
    Antimicrob Agents Chemother; 1998 May 10; 42(5):1306-7. PubMed ID: 9593177
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.